Epidermal growth factor receptor-mutant lung cancer in Down syndrome: a case presentation and review of the literature

BACKGROUND: Solid tumors have a markedly decreased incidence in individuals with Down syndrome (DS), including lung cancers. METHODS: The clinical presentation of epidermal growth factor receptor (EGFR)-mutant non-small-cell lung cancer (NSCLC) in DS was reported and literature on the subject review...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xin, Xing, Shijiang, Dong, Qiumei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589697/
https://www.ncbi.nlm.nih.gov/pubmed/28903458
http://dx.doi.org/10.18632/oncotarget.17406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589697/
https://www.ncbi.nlm.nih.gov/pubmed/28903458
http://dx.doi.org/10.18632/oncotarget.17406

Ejemplares similares